Brief: Lifecore Biomedical Posts Qtrly Loss Per Share Of $0.42

Lifecore Biomedical

16/03/2023 22:05

March 16 (Reuters) - Lifecore Biomedical Inc  LFCR.O :
    * LIFECORE BIOMEDICAL REPORTS SECOND QUARTER FISCAL YEAR
2023
RESULTS
    * LIFECORE BIOMEDICAL INC - QTRLY CONSOLIDATED REVENUES OF
$38.8
MILLION
    * LIFECORE BIOMEDICAL INC -  QTRLY LOSS PER SHARE $0.42;
QTRLY
ADJUSTED LOSS PER SHARE $0.24
    * LIFECORE BIOMEDICAL - WITHDRAWING PREVIOUSLY ANNOUNCED FY
2023
GUIDANCE DUE TO CO'S ANNOUNCEMENT OF ITS INTENTION TO EXPLORE
STRATEGIC ALTERNATIVES

Source text for Eikon:  ID:nGNX7s9lrJ 
Further company coverage:  LFCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))